Oral Metformin for Treating Melasma in Latin American Women

ConditionMelasma
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age21+
SponsorUniversity of Puerto Rico

About this trial

The goal of this clinical trial is to learn if metformin can treat melasma in Latin American women. The main question it aims to answer is:

\- Can metformin help reduce the dark patches of melasma?

Researchers will test two different doses of metformin (500 mg and 1000 mg) to see if either one helps improve melasma.

Participants will:

* Take a metformin pill every day for three months. * Go to the clinic twice: once at the beginning and once at the end of the study. * Get a phone call from the researchers to check how they're doing and ask about any changes or side effects.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Metformin

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators